The use of preanalytical quality indicators: a Turkish preliminary survey study

Abstract

ObjectivesThe utilization of reliable quality indicators (QIs) proven to be suitable for monitoring and improvement tools is one of the best choices to minimize of the risk of errors in all laboratory processes called as total testing process (TTP). In 2008, a Working Group “Laboratory Errors and Patient Safety” (WG-LEPS) established by International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) developed the Model of Quality Indicators (MQI) complying with requirements of the ISO 15189:2012 standard for laboratory accreditation. They have also been dealing with harmonizing the QIs in most laboratories worldwide since then. The present study was set out to investigate the frequency of using IFCC WG-LEPS’ pre-QIs by Turkish laboratories and to assess the conformity of them, by taking into account Turkey’s conditions.MethodsA survey consisting nine questions was applied in 81 laboratories using SurveyMonkey.ResultsAccording to the survey results, most of the laboratories reported they have used pre-QIs in the quality standards of health prepared by Turkish Ministry of Health (MOH). A part of IFCC WG-LEPS’ pre-QIs were being utilized by more than 80% of the laboratories, the rest of which only used by 10% of laboratories.ConclusionsThe majority of the medical laboratories have been using the pre-QIs included in the guidelines of Quality Standards prepared by the MOH. The pre-QIs are partially compatible with IFCC WG-LEPS’ pre-QIs. The definitions of IFCC WG-LEPS’ pre-QIs may also be revised to make them more clear and understandable by IFCC WG-LEPS. The insufficiency of Health Information Management Systems (HIMS) limits the use of pre-QIs proposed by IFCC WG-LEPS. Finally, the education of relevant personnel about the use of HIMS and pre-QIs is very crucial to harmonize and to extend the use of IFCC WG-LEPS’ pre-QIs in Turkish medical biochemistry laboratories.

Preanalytical Errors in Clinical Biochemistry Laboratory and Relationship With Hospital Departments and Staff: A Record-Based Study

“…18 In Turkey, laboratories are periodically inspected by the Ministry of Health in line with the Quality Standards and Hospital Efficiency On-site Evaluation Guide prepared by the ministry. 19 In our study, the insufficient sample, which constituted almost half of the causes of preanalytical errors, was in the first place, followed by the clotted and inappropriate sample. It is seen that similar reasons take the first 3 places in the literature, although their locations vary.…”

“…The working group for the preanalytical phase of the European Union has been carrying out many projects since 2013, such as harmonizing the definition of fasting status, identification of patients and blood tubes, color coding of blood collection tubes, and sequencing and development of tubes during blood collection 18 . In Turkey, laboratories are periodically inspected by the Ministry of Health in line with the Quality Standards and Hospital Efficiency On-site Evaluation Guide prepared by the ministry 19 …”

Blood gas analysis syringes containing spray-dosed droplet liquid heparin may decrease sample rejection ratios

“…As in most of the laboratories in Turkey, our laboratory also follows the recommendations published by the Ministry of Health of the Republic of Turkey for the purpose of SRR evaluation (32). Out of such criteria, the most frequently encountered 10 criteria for sample rejection as applicable to BGA evaluation were listed below: ).…”

Pancreatite Aguda E Covid-19: Uma Revisão Da Literatura

“…Plebani;Sciacovelli;Aita (2017) complementam alegando que para facilitar a compreensão e coleta dos dados, os IQs foram divididos em grupos, sendo: quatro medidas para erros de identificação, seis medidas erros de transcrição de teste, sete para amostras inadequadas, cinco para amostras inadequadas devido a problemas no transporte e armazenamento, sete para avaliar a adequação do tempo de liberação dos resultados e uma para relatório do laboratório incorreto. Orhan et al (2020) avaliaram em seus estudos a frequência do uso de indicadores pré-analíticos do IFCC WG-LEPS em laboratórios turcos, onde a maioria era filiado ao Ministério da Saúde do país, e mais de 80% utilizavam parte dos indicadores estabelecidos em relação as amostras, com volume insuficiente (87%); coagulado (85%); rejeitado por hemólise (84%) e recolhido em recipiente errado (84%), ou seja, os indicadores do MQI e utilizado pela maioria dos laboratórios e acredita-se que a tradução, que já está em curso, para língua dos participantes irá favorecer a participação de demais laboratórios no projeto.…”